A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients
Hong Zeng, Xitong Geng, Hao Wan, Xiaoyu Qu, Shengwei Tang, Ruiyu Zhang, Minqin Zhou, Zichuan Yu, Jingying Pan, Hao Zheng, Yanting Zhu, Shuhan Huang, Da Huang · 2024
Read A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients by Hong Zeng, Xitong Geng, Hao Wan, Xiaoyu Qu, Shengwei Tang, Ruiyu Zhang, Minqin Zhou, Zichuan Yu, Jingying Pan, Hao Zheng, Yanting Zhu, Shuhan Huang, Da Huang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11627108.txt.
Description
Hong Zeng and co-authors hunt for a gene-based forecast for thyroid cancer, built from the cell's protein disposal system, the ubiquitin-proteasome system. When that system slips, damaged proteins pile up and cancer can follow. Using a large public cancer database, the team ran network and regression analyses to pick the disposal genes that track patient outcomes.
Six genes formed a score that split patients into groups with clearly different outlooks. High scores came with a suppressed immune setting around the tumor. One gene, KCNA1, stood out as the hub of the model: patients whose tumors made more of it resisted the drug gemcitabine, while silencing it restored sensitivity. The authors also mapped a small regulatory network around that gene. They propose the score and its hub gene as guides for prognosis and for immune or drug treatment choices.
Catalog record
| CREATOR | Hong Zeng, Xitong Geng, Hao Wan, Xiaoyu Qu, Shengwei Tang, Ruiyu Zhang, Minqin Zhou, Zichuan Yu, Jingying Pan, Hao Zheng, Yanting Zhu, Shuhan Huang, Da Huang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |